Brand matters! Independent landmark study shows lower failure rate with Straumann dental implants.
Peri-implantitisNew insights
Peri-implantitisInflammation affecting the soft tissue and bone around dental implants.
If not treated it can lead to implant loss.
Healthy tissue
Contributing factors
Smoking Number of implants
Limited oral hygiene
Prosthetic therapy
Implant system
Peri-implantitis
History of periodontitis
39.4 %
32.7 %18.4 %
Study overview1–2
Swedish Social Insurance Agency, Stockholm
~ 25.000implant patients
in 2003
427patients randomly
selected
9 years 3 systemsafter treatment patients
were retrospectively analyzed for
peri-implantitis
represented over 90 % of the implants3
9.4 %
Nobel Biocare
StraumannTissue Level
SLA implant
Others
(Adapted from Derks et al.1 )
Astra Tech Implant System
Result
The findings in this study are extremely relevant for dentists and patients who base their choice of implant on independent clinical evidence. These results add weight to previous reported findings showing high success rates with Straumann implants.5
The probability of being diagnosed with peri-implantitis4 9 years after implant therapy was lowest with the Straumann TL SLA implants.
Conclusion
Implants (≥ 4) used by specialist in patients with no periodontitis
(Adapted from Derks et al.1)
%
StraumannNobel Biocare OthersAstra Tech Implant System
10 % 9 %
14 %
3 %
25
20
15
10
5
0
Implants (≥ 4) used by specialist in patients with periodontitis(Adapted from Derks et al.1)
Astra Tech Implant System
%
StraumannNobel Biocare Others
30 %
11 %
50
40
30
20
10
0
29 %
38 %
19%
40%
32%
Independent landmark study shows significantly lower failure rate with Straumann dental implants.
More than a dental implant – brand matters
Study design
Shor
t-ter
m
Early implant loss = If im-plant loss had occurred prior to connection of the supraconstruction
Study duration Patient number Implant number Investigated brands
2765 11 311
Swedish Social Insurance Agency
Long
-ter
m
Late implant loss = Evaluated 9 years after therapy
596 2367
19%
41%
30%
Nobel Biocare
Straumann
Others
Astra TechImplantSystem
10 %
StraumannOthers
Astra TechImplantSystem
9%
Nobel Biocare
ResultsRisk of implant loss compared to Straumann dental implants,
expressed as “odds ratio” (OR)overall
154 implants lost (1.4 %);
121 patients affected (4.4 %).
StraumannNobel Biocare
X 1.94statistically significant
Astra TechImplant System
X 2.10statistically significant
Other Brands
X 7.79statistically significant
Early
impl
ant l
oss
Late
impl
ant l
oss
46 implants lost (2.0 %);
25 patients affected (4.2 %).
Straumann Nobel Biocard
X 6.13not statistically
significant
Astra TechImplant System
X 5.23not statistically
significant
Other Brands
X 58.15statistically significant
If implant loss had occurred prior to connection of the supraconstruction, it was scored as an early implant loss. If the loss had occurred afterward, it was considered a late implant loss.
ConclusionThese findings are extremely relevant for dentists and patients who want to choose an implant system on the basis of independent published clinical evidence. They add to the unparalleled body of long-term clinical data supporting Straumann’s dental implant system. Impressive long-term outcomes have been reported with Straumann implants in other peer-reviewed publications, including 10-year survival rates of 97 – 99 % in more than 600 patients1.
Brand matters!Because one implant failure is one too much.
Source
1 J. Derks*, J. Håkansson, J.L. Wennström, C. Tomasi, M. Larsson, and T. BerglundhEffectiveness of Implant Therapy Analyzed in a Swedish Population – Early and Late Implant Loss
2 Retrospective evaluation of data from Swedish Social Insurance Agency.
3 98.3% Nobel Biocare Implants had a TiUnite® surface, 96.6% Astra Tech implants a TiOblast® surface, all Straumann TL implants a SLA® surface. Adapted from Derks et al.
4 Defined as Bleeding on probing (BoP)/suppuration (SUP) and bone loss > 2mm.
5 Buser D et al Clin Implant Dent Relat Res. 2012 Dec;14(6):839-51. Roccuzzo M et al Clin Oral Implants Res. 2014 Oct;25(10):1105-12. van Velzen FJ et al Clin Oral Implants Res. 2014 Nov 5. Fischer K et al Clin Implant Dent Relat Res. 2012 Dec;14(6):808-15.
Derks J. et al. Published online before print December 11, 2014, doi: 10.1177/0022034514563077 JDR December 11, 2014 0022034514563077http://jdr.sagepub.com/content/early/2014/12/11/0022034514563077.abstract?rss=1
Astra Tech Implant System is a registered trademark of Dentsply IH AB
Nobel Biocare is a registered trademark of Nobel Biocare AB, SE
490.068/A/00 04/15
You matter to us!You are our inspiration. To show you our appreciation, we would like to offer you a Straumann power bank for free. Write us an e-mail to [email protected] with your contact details and we will send it to you. Would you mind mentioning in your mail why the brand mat-
ters to you? We are very interested to know.